NCT03318874View on ClinicalTrials.gov

Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 19, 2017

Primary Completion Date

April 15, 2020

Study Completion Date

November 17, 2021

Conditions
Dry Eye SyndromesMeibomian Gland Dysfunction
Interventions
DEVICE

Blephasteam

Steam delivery goggles, once daily

DEVICE

THERA°PEARL Eye Mask

Heat delivery device, delivering heat to the eyelids, once daily

DRUG

Hylo-comod

Tear substitute containing hyaluronic acid, four times daily

Trial Locations (1)

0369

The Norwegian Dry Eye Clinic, Oslo

All Listed Sponsors
collaborator

Schepens Eye Research Institute

OTHER

collaborator

The Norwegian Dry Eye Clinic

OTHER_GOV

lead

Oslo University Hospital

OTHER

NCT03318874 - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter